Improving Outcomes for Transplant Patients: Contribution of a Dental Hygienist

Schubert, 2004, Oral complications, 911 2013 Ogle, 2000, Cancer and comorbidity redefining chronic diseases, Cancer, 88, 653, 10.1002/(SICI)1097-0142(20000201)88:3<653::AID-CNCR24>3.0.CO;2-1 Flowers, 2011, Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according the National Institutes of Health consensus criteria, Blood, 117, 3214, 10.1182/blood-2010-08-302109 Lee, 2008, Recognizing and managing chronic graft versus host disease, Hematology Am Soc Hematol Educ Program, 134, 10.1182/asheducation-2008.1.134 Goodrich, 1991, Early treatment with ganciclovir to prevent cytomegalovirus disease after allogeneic bone marrow transplantation, N Engl J Med, 325, 1601, 10.1056/NEJM199112053252303 Lloid, 1994, Cytomegalovirus infection of the tongue following marrow transplantation, Bone Marrow Transplant, 14, 99 2004, Thomas' hematopoietic cell transplantation, xix Schubert, 1987, The use of benzydamine HCL for the management of cancer therapy-induced mucositis: preliminary report of a Multicenter Study, Int J Tissue React, IX, 99 Schubert, 1992, Clinical assessment scale for the rating of oral mucosal changes associated with bone marrow transplantation. Development of an oral mucositis index, Cancer, 69, 2469, 10.1002/1097-0142(19920515)69:10<2469::AID-CNCR2820691015>3.0.CO;2-W Inamoto, 2011, Treatment of chronic graft versus host disease, Curr Opin Hematol, 18, 414, 10.1097/MOH.0b013e32834ba87d Devic, 2014, Proteomic analysis of saliva from patients with oral chronic graft-versus-host disease, Biol Blood Marrow Transplant, 20, 1048, 10.1016/j.bbmt.2014.03.031 Federmann B, Weidmann J, Blumenstock G, et al. Incidence and Characterization of Taste Disturbances After Allogeneic of Autologous Hematopoietic Stem Cell Transplantation Using Myeloablative or Reduced-intensity Conditioning. 51st American Society of Hematology Annual Meeting and Exposition, December 7, 2009. Available at: https://ash.confex.com/ash/2009/webprogram/Paper20882.html. Accessed on October 1, 2013. Abasaeed, 2015 Lloid, 1995, Oral medicine concerns of the BMT patient, 257 Brennan MT, Elting LS, Spijkervet FKL. Evidence based management strategies for oral complications from cancer treatment. Oral Care Study Group, Multinational Association of Supportive Care in Cancer (MASCC)/International Society of Oral Oncology (ISOO). 2010;18:979-984. NIH National Institute of Dental and Craniofacial Research oral complications of cancer treatment: what the dental team can do. Available at: http://www.nidcr.nih.gov/oralHealth/Topics/CancerTretament/OralComplicationsCancerWhatthedentalteamcando. Accessed November 20, 2016. Migliorati, 2010, A systematic review of bisphosphonate osteonecrosis (BONJ), Support Care Cancer, 18, 1099, 10.1007/s00520-010-0882-1